DELIVERY ORDER
Active75N93026F00001
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$844.8K
obligated · signed 2 months ago
EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS.
Performance timeline
Start
Sep 15, 2026
End
Sep 14, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 14, 2027
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Contract 75N93026F00001
UEI
MSPWVMXXMN76
Parent Company
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Capabilities & Certifications
Headquarters Location
Congressional District: 14
Current Obligation
$844,795
Base + Exercised Options
$844,795
Total Ceiling Value
$5,329,933
Contract Type
COST NO FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 14
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93024D00042
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.